> Imprima

GM-CSF for Melanoma

Ultima Vez Modificado: 22 de marzo del 2010

Question

Dear OncoLink "Ask The Experts,"
I was diagnosed with melanoma on my left foot, Stage Ib, in 2005. In 2009, I was found to have a recurrence in the left thigh. This was removed and there appears to be no organ involvement. I do not want to take any toxic treatments and am wondering about your thoughts on GM-CSF, which is my plan for treatment.

Thank you!

Answer

Keith T. Flaherty, MD, Assistant Professor of Medicine (Hematology/Oncology), responds:

GM-CSF as adjuvant therapy continues to be investigated in clinical trials, with no clear signal yet as to whether or not it helps to prevent recurrences of melanoma. It is clearly a well-tolerated therapy and therefore, has little going against it in that respect. There are ongoing trials testing the value of GM-CSF by itself, and others that are combining the therapy with other immunological therapies, such as vaccines. In conclusion, right now, the jury remains out on GM-CSF, and you should discuss the pros and cons of this therapy in your particular case with your oncologist(s).

Blogs

I wish u knew... Skin cancer 101
by Timothy J. Hampshire
January 28, 2013

Don't Assume You Understand
by Bob Riter
July 29, 2015

Related News

But supplements may lower risk of melanoma for women with a history of nonmelanoma skin cancer

Jun 30, 2011

But supplements may lower risk of melanoma for women with a history of nonmelanoma skin cancer


ASCO: Nicotinamide May Help Prevent Non-Melanoma Skin CA

May 15, 2015

Preliminary Australian study saw association between nicotinamide and lower rates


AAD: Study Examines Incidence of Non-Melanoma Skin Cancer

Mar 21, 2015

Incidence of NMSC much higher among Caucasians; Hispanic patients significantly younger